Related Experiment Video

Updated: Apr 19, 2026

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
07:32

Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

Published on: September 1, 2023

2.5K

A promising CpG adjuvant-loaded nanoparticle-based vaccine for treatment of dust mite allergies

Aliasger K Salem

    Immunotherapy
    |December 16, 2014
    PubMed
    Abstract

    No abstract available in PubMed .

    Keywords:
    CpGDer p2PLGAallergyasthmabiodegradablehouse dust mite allergensnanoparticles

    More Related Videos

    Harvesting Murine Alveolar Macrophages and Evaluating Cellular Activation Induced by Polyanhydride Nanoparticles
    11:26

    Harvesting Murine Alveolar Macrophages and Evaluating Cellular Activation Induced by Polyanhydride Nanoparticles

    Published on: June 8, 2012

    20.5K
    Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
    06:02

    Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

    Published on: February 23, 2024

    1.4K

    Related Experiment Videos

    Last Updated: Apr 19, 2026

    Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection
    07:32

    Evaluating the Immune Response of a Nanoemulsion Adjuvant Vaccine Against Methicillin-Resistant Staphylococcus aureus MRSA Infection

    Published on: September 1, 2023

    2.5K
    Harvesting Murine Alveolar Macrophages and Evaluating Cellular Activation Induced by Polyanhydride Nanoparticles
    11:26

    Harvesting Murine Alveolar Macrophages and Evaluating Cellular Activation Induced by Polyanhydride Nanoparticles

    Published on: June 8, 2012

    20.5K
    Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination
    06:02

    Author Spotlight: Development and Evaluation of a Cationic Nanoemulsion-Encapsulated Retinoic Acid System for Mucosal Vaccination

    Published on: February 23, 2024

    1.4K

    Related Concept Videos

    Allergic Reactions02:06

    Allergic Reactions

    34.4K
    Overview
    34.4K
    Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

    Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

    2.5K
    Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
    Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
    2.5K

    Articles linked to this work by shared authors, journal, and citation graph.

    Ferritinophagy Contributes to Iron Accumulation and Ferroptosis in Fuchs Endothelial Corneal Dystrophy.

    bioRxiv : the preprint server for biology·2026

    A review of exosomes as nanomedicine for antimicrobial delivery and combating antimicrobial resistance.

    International journal of pharmaceutics·2026

    Nanoparticle Co-delivery of Microtubule Inhibitors and Cisplatin Overcomes DNA Repair-Mediated Resistance in Head and Neck Cancer.

    Molecular cancer therapeutics·2026

    Targeting the NAD+-PARP1-XRCC1 axis in ALS.

    Trends in molecular medicine·2026

    A nanovaccine induces durable and functional MUC4-targeted T cell responses against pancreatic cancer.

    Acta biomaterialia·2026

    Peripheral vaccination-induced brain-resident memory CD8+ T cells durably protect mice against intracranial malignancy.

    The Journal of clinical investigation·2026

    Baseline circulating immunophenotype as a predictor of immune-related adverse events in NSCLC patients treated with immune checkpoint inhibitors.

    Immunotherapy·2026

    Real-world efficacy and safety of neoadjuvant immunochemotherapy in patients with triple-negative breast cancer.

    Immunotherapy·2026

    Circulating and tumor microenvironment immunomarkers associate with immunotherapy efficacy in advanced bladder urothelial carcinoma: an exploratory multicenter study integrating genomic and immunophenotypic profiling.

    Immunotherapy·2026

    Efgartigimod in the treatment of severe Guillain-Barre syndrome with overlapping autoantibody syndrome: a case report and updated clinical review.

    Immunotherapy·2026

    Association of early dynamic changes in peripheral blood immune-inflammatory indices with subsequent acquired resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer: a landmark analysis.

    Immunotherapy·2026

    Liquid-liquid phase separation-related gene can predict prognosis and influence immune microenvironment in acute myeloid leukemia.

    Immunotherapy·2026

    Identification of Human Nectin-4 and Signaling Lymphocyte Activation Molecule/SLAM as Potential Receptors for the Spike Protein of SARS-CoV-2 and its Variants.

    Current drug targets·2026

    Unlocking Goji berries polysaccharides: therapeutic potential, biomedical implications and future trends.

    Food & function·2026

    Multiple Clinical Applications of a Dialkylcarbamoyl Chloride (DACC)-Coated Dressing in the Management of an Extensive Skin Defect: A Case Report.

    Cureus·2026

    Advances in biosynthesis and sensory property modulation of mogrosides.

    Food research international (Ottawa, Ont.)·2026

    High-affinity ELR+ CXC chemokines display balanced G protein-, GRK- and β-arrestin-associated transducer engagement at the viral G protein-coupled receptor ORF74.

    Frontiers in pharmacology·2026

    Molecular Determinants of G Protein Subtype-Specific Coupling to the Angiotensin II Type 1 Receptor.

    bioRxiv : the preprint server for biology·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us